Clinical trials: Waldenström Macroglobuloinemia
Waldenström Macroglobuloinemia
Phenotypic and Functional Study of Bone Marrow Mesenchymal Stem Cells in Waldenström Macroglobulinemia
Waldenström disease (WM) is defined by the presence of bone marrow lymphoplasmocytes and monoclonal immunoglobulin M (IgM). Treatment should be initiated in cases of cytopenia, tumor syndrome or when the physicochemical or…
- Trial name
- SLP-rares-CSM (NCT07471074)
- Testing
- sample of bone marrow cells
- Where
- France
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Universitaire, Amiens